Stable Ischemic Heart Disease: What Do the 2012 Guidelines Say?
Faisal Latif, MD, Assistant Professor, Department of Medicine/Cardiovascular (1.0 AMA PRA Category 1 Credit™). This activity has no commercial support.
Objectives: Upon completion of this activity, participants will be able to: Review the scope of stable ischemic heart disease. To identify the survival benefits of surgical and percutaneous revascularization. To evaluate various aspects of management of stable ischemic heart disease. Speaker: Dr. Latif has no financial relationships or affiliations to disclose.
Disclosure Report: Course Director: Dr. C.A. Sivaram is a consultant for and has received honorarium from ATS Medical. Planning Committee Members: Dr. Dwight Reynolds has received grants/research support and been a consultant for Medtronic. Course Contact: Ms. Kelsey Peters has no financial relationships or affiliations to disclose. Speaker: Dr. Dasari has no financial relationships or affiliations to disclose.Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters/authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability. Eery reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.
For more information contact:
Department of Medicine/Cardiovascular Diseases